131 related articles for article (PubMed ID: 27345985)
1. Generation of Hermansky Pudlak syndrome type 2 (HPS2) induced pluripotent stem cells (iPSCs).
Maguire JA; Lu L; Mills JA; Sullivan LM; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):287-9. PubMed ID: 27345985
[TBL] [Abstract][Full Text] [Related]
2. Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).
Maguire JA; Lu L; Mills JA; Sullivan LM; Gagne A; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):233-5. PubMed ID: 27345974
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a control and patient-derived human iPSC line containing the Hermansky Pudlak type 2 (HPS2) associated heterozygous compound mutation in AP3B1.
Aarts CEM; Karampini E; Wüst T; Webbers S; Varga E; Geissler J; Voorberg J; von Lindern M; Bierings R; van den Akker E; Kuijpers TW
Stem Cell Res; 2021 Jul; 54():102444. PubMed ID: 34182253
[TBL] [Abstract][Full Text] [Related]
4. Generation of HEXA-deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient.
Liu Z; Zhao R
Stem Cell Res; 2016 Sep; 17(2):289-291. PubMed ID: 27879213
[TBL] [Abstract][Full Text] [Related]
5. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
6. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
7. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
[TBL] [Abstract][Full Text] [Related]
8. Hermansky-Pudlak syndrome: Report of two patients with updated genetic classification and management recommendations.
Loredana Asztalos M; Schafernak KT; Gray J; Berry A; Paller AS; Mancini AJ
Pediatr Dermatol; 2017 Nov; 34(6):638-646. PubMed ID: 29044644
[TBL] [Abstract][Full Text] [Related]
9. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2.
Huizing M; Scher CD; Strovel E; Fitzpatrick DL; Hartnell LM; Anikster Y; Gahl WA
Pediatr Res; 2002 Feb; 51(2):150-8. PubMed ID: 11809908
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
13. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
16. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
[TBL] [Abstract][Full Text] [Related]
17. An integration-free, virus-free rhesus macaque induced pluripotent stem cell line (riPSC89) from embryonic fibroblasts.
Sosa E; Kim R; Rojas EJ; Hosohama L; Hennebold JD; Orwig KE; Clark AT
Stem Cell Res; 2016 Sep; 17(2):444-447. PubMed ID: 27879222
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
19. Generation of Integration-Free Patient Specific iPS Cells Using Episomal Plasmids Under Feeder Free Conditions.
Caxaria S; Arthold S; Nathwani AC; Goh PA
Methods Mol Biol; 2016; 1353():355-66. PubMed ID: 25701132
[TBL] [Abstract][Full Text] [Related]
20. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
